Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
30.96
+0.16 (0.52%)
Aug 13, 2026, 3:17 PM AST

TADAWUL:2070 Cash Flow Statement

Millions SAR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
214.39184.3624.54-50.73-165.1426.45
Depreciation & Amortization
81.8686.8578.8476.1984.9383.66
Other Amortization
10.2710.275.865.823.894.44
Loss (Gain) From Sale of Assets
-9.86-28.7-18.94-6.38-0.140.45
Asset Writedown & Restructuring Costs
3.692.6817.370.05--
Loss (Gain) From Sale of Investments
36.5521.337.0642.05-3.63-7.81
Loss (Gain) on Equity Investments
-22.03-24.35-22.73-20-20.44-11.41
Stock-Based Compensation
0.181.711.18---
Provision & Write-off of Bad Debts
----10.05-13.86
Other Operating Activities
-12.0413.16-73.92160.4111.05-6.84
Change in Accounts Receivable
-92.94-23.18-341.48-190.08172.6918.02
Change in Inventory
50.6725.78-49.6-143.03-76.5613.02
Change in Accounts Payable
-125.51-59.39116.37128.35-57.96-14.27
Change in Other Net Operating Assets
7661.89-105.58.22-44.37-3
Operating Cash Flow
202.33272.35-330.9610.87-99.386.71
Operating Cash Flow Growth
-----790.67%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-88.14-89.14-71.27-106.79-78.21-76.24
Sale of Property, Plant & Equipment
12.939.5535.557.530.651.02
Sale (Purchase) of Intangibles
-9.29-10.44-31.01-5.94--1
Investment in Securities
18.55-24.98-39.5-70.5525.89193.74
Other Investing Activities
--13.198.7536.323.97
Investing Cash Flow
-65.98-85.01-93.05-166.94484.63141.48

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,6121,2901,497-14.47
Long-Term Debt Repaid
--1,717-894.41-1,462-220.55-81.35
Net Debt Issued (Repaid)
-134.57-104.78395.8234.61-220.55-66.87
Repurchase of Common Stock
---11.94-8--
Common Dividends Paid
-40.76--2.78-0.46-70.74-118.11
Other Financing Activities
-11.960.87--26.19-49.86-55.97
Financing Cash Flow
-187.3-103.91381.11-0.04-341.15-240.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
4.09-1.671.95-16.15-38.58.35
Net Cash Flow
-46.8681.76-40.95-172.265.69-4.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
114.2183.21-402.23-95.92-177.5110.47
Free Cash Flow Growth
------
Free Cash Flow Margin
6.57%10.73%-23.91%-5.79%-12.48%0.72%
Free Cash Flow Per Share
0.961.53-3.37-0.80-1.480.09
Levered Free Cash Flow
47.9896.42-353.9541.76-121.09-56.73
Unlevered Free Cash Flow
97.9152.06-299.7281.45-99.63-37.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
86.5372.3108.1569.8233.4120.26
Cash Income Tax Paid
-----0.54
Change in Working Capital
-100.685.09-380.21-196.54-6.213.78